1C.R. Dearolf is director of program development and support, Office of Intramural Research, National Institutes of Health, Bethesda, Maryland.

2J.S. Lee is deputy director for intramural clinical research, Office of Intramural Research, National Institutes of Health, Bethesda, Maryland.

3C.L. Pickett is senior science policy analyst, Office of Portfolio Analysis, National Institutes of Health, Bethesda, Maryland.

4G. Santangelo is director, Office of Portfolio Analysis, National Institutes of Health, Bethesda, Maryland.

5N.F. Schor is deputy director for intramural research and director, Office of Intramural Research, National Institutes of Health, Bethesda, Maryland; ORCID: https://orcid.org/0000-0002-3817-7376.

Correspondence should be addressed to Nina F. Schor, Office of the Director, National Institutes of Health, 1 Center Dr., Bethesda, MD 20892; telephone: (301) 496-1921; email: [email protected].

Supplemental digital content for this article is available at https://links.lww.com/ACADMED/B561.

Acknowledgments: The authors would like to thank the Lasker Foundation for its partnership in development of the careers of the next generation of clinician-scientists. The authors also would like to thank the members of the 2 blue ribbon panels that provided guidance to us as the Lasker Clinical Research Scholars Program has grown and progressed during the past decade.

Funding/Support: The Lasker Clinical Research Scholars Program is funded by the Intramural Research Program of the NIH and by the extramural research programs of the NIH for those scholars who receive the second-phase R00 grant funding.

Other disclosures: None reported.

Ethical approval: This study was approved as exempt by the NIH Office of Institutional Review Board Operations, February 1, 2024.